An interventional study of Virtual Reality baseline assessment in Cerebral Palsy and Healthy Volunteers, sponsored by IRCCS Eugenio Medea. Completed at 1 site in Italy. Open to participants aged 13 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-10.
Sponsored by IRCCS Eugenio Medea · Not applicable, Interventional, and Basic science
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 18 studies in Cerebral Palsy by IRCCS Eugenio Medea — 8 open to participants now, 8 under way, none of them phase 3. Cerebral Palsy · IRCCS Eugenio Medea.
Among the 18 studies in Cerebral Palsy by IRCCS Eugenio Medea, this one is the 8th largest by enrollment of the 11 interventional ones that give a count, is one of 3 that started in 2023, is one of 11 with no phase, and was the 9th registered.
1,942 studies on the registry are indexed under Cerebral Palsy; 456 are open to participants now.
Browse Cerebral Palsy studies →8 of the 18 studies in Cerebral Palsy by IRCCS Eugenio Medea are open now, in 1 country. Recruiting first, the newest first:
IRCCS Eugenio Medea · Sites in Italy
Ages 6–14
IRCCS Eugenio Medea · Sites in Italy
Ages 4–80 · Healthy volunteers
IRCCS Eugenio Medea · Sites in Italy
Ages 8–17 · Healthy volunteers
IRCCS Eugenio Medea · Sites in Italy
Ages 5–17
IRCCS Eugenio Medea · Sites in Italy
Ages 36 mo–5 yrs
By country, each count listing its studies:
Of the 271 Cerebral Palsy studies recruiting now, 26 (10%) set no upper age limit and 237 (87%) stop at 75 or younger; 256 take children under 18; 53 take healthy volunteers.
This study: 13 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
18 studies; the count open now beside each. This study's row is marked.
First in 2016; this study’s year is marked. 3 started in 2023.
This study's enrollment of 37 is close to the median of 34 across 1,434 interventional studies indexed under Cerebral Palsy.
Median enrollment 44 across the 11 interventional studies, 59 across the 7 observational. Of the 10 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
IRCCS Eugenio Medea is the lead sponsor of 109 studies on the registry; 52 are open to participants now.
1 of the studies in Cerebral Palsy by IRCCS Eugenio Medea that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06622655IRCCS Eugenio MedeaClinical Improvement Due to the Home Use of Agilik in Children With Cerebral Palsy | 2026-11 |
Add it to your calendar (.ics) → With an account.
Among the 18 studies in Cerebral Palsy by IRCCS Eugenio Medea, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Spatial navigation skills are very important in everyday activities and quality of life but spatial navigation abilities are not part of the standard process of assessment and rehabilitation of patients. Furthermore, it is known that children with cerebral palsy have impaired visuo-spatial competences. The main objective of this study is to evaluate and compare the spatial navigation abilities of typically developing children and of children with cerebral palsy using the "StarMaze" application delivered by means of a Head Mounted Display (HMD). The second aim is to investigate the user experience during the session. A similar application was already developed and tested in a virtual reality large scale platform whose size and cost limit the accessibility. Therefore, the assessment (and future training) of navigation abilities with affordable and easy-to-use technology such as HMD open new perspectives.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants with cerebral palsy are recruited.
Other: Virtual Reality baseline assessment
Typically developing children are recruited.
Other: Virtual Reality baseline assessment
They undergo a baseline assessment (including cognitive level and pen and paper tests for visuo-spatial abilities). Then they perform a spatial navigation assessment with an immersive virtual reality application delivered by the Oculus Quest viewer. The spatial navigation application consists of a 5-way star-maze adapted from (Biffi et al 2020 Front. Psychol.) where the participants have to find a treasure hidden at the end of one way. The application measures both the learning of spatial information and the strategy used (egocentric or allocentric). After the session, the participants fill questionnaires related to cyber-sickness and usability of the application.
Navigation strategy
The navigation strategy is measured by the application "StarMaze" delivered by the Oculus Quest viewer and it could be egocentric or allocentric. The strategy is egocentric if the participant finds the treasure in the virtual space by using a self-centred trajectory. The strategy is allocentric if the participant find the treasure in the virtual space by using a trajectory based on environmental cues.
Time frame: One day
Learning rate
The learning rate of correct path to follow to find the treasure strategy is measured by the application "StarMaze" delivered by the Oculus Quest viewer. It is the number of trials required by the participant to reach a stable performance
Time frame: One day
Simulator Sickness Questionnaire
The questionnaire evaluates the effects of cyber sickness. Participants have to score 16 symptoms on a four-point scale (0-3).The symptoms can be placed into three general categories: oculomotor, disorientation, and nausea. Weights are assigned to each of the categories and summed together to obtain a single score.
Time frame: One day
System Usability Scale
It evaluates the usability of the system. The SUS is a simple, ten-item five-point Likert scale giving a global view of subjective assessments of usability.
Time frame: One day
Independent Television Commission-Sense of Presence Inventory
It is a 5-point Likert scale, composed of 44 items. This questionnaire evaluates the user experience to understand if the person enjoyed the game, the setting, and the overall experience. In particular, the questionnaire addresses four factors: spatial presence, engagement, realness of the environment, and side effects (cyber sickness).
Time frame: One day
Suitability Evaluation Questionnaire - simplified version
It evaluates the sense of agency with four questions (likert scale 1-5) and one open question.
Time frame: One day
Short-form of PANAS-Positive Affect and Negative Affect Scales
In the questionnaire, the participant must evaluate how much s/he feels in the way described by the adjective when filling out the questionnaire, responding on a 5-point Likert scale. The PANAS provides measures of Positive Affects (PAs) and Negative Affects (NAs). The PA and NA scores are the sums of the ratings of the PA items and the NA items, respectively. PA indicates the level of pleasurable engagement with the product while NA is a general factor of subjective distress.
Time frame: One day
Ran from Feb 2023 to primary completion in Oct 2026, 44 months.
Of 906 non-industry interventional studies with no phase under Cerebral Palsy, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 31. This study's 44 months is above that.
Counting every sponsor, half of 925 studies reached it within 12 months; a quarter within 5 and three quarters within 31.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 10, 2026: primary completion Dec 2026 → Oct 2026 and completion Dec 2026 → Oct 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.